Sign in
4

Changes in Ownership

LIGAND PHARMACEUTICALS INC Filed Acc 0001104659-24-031806

Director sold 1,893 shares at $74.30 ($140,650)

  • Director acquired 2,893 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Sabba Stephen L · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-03-05 Exercise or conversion : show line 1 in the form +2,893 30,819 D
2024-03-05 Sale : show line 2 in the form −1,893 $74.30 $140,650 28,926 D
Open-market sales · 1,893 sh · avg $74.30 · $140,650

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-03-05 Exercise or conversion : show line 3 in the form Non-Qualified Stock Option (right to buy) −2,893 419 D
Loading xslF345X05/tm248239-1_4seq1.xml…